> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER Protein Therapeutics Director Joins EpiVax
- URL: https://www.fdaweb.com/cder-protein-therapeutics-director-joins-epivax/
- Published: 2021-07-06T12:00:00.000Z
- Updated: 2026-09-14T17:05:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5149645

After 20 years at FDA, CDER Division of Therapeutic Proteins director **Amy Rosenberg** is leaving to join EpiVax as senior director of immunology and protein therapeutics. Rosenberg’s work at the agency was focused on immune tolerance induction and immunogenicity, and she oversaw the regulation and approval of numerous protein therapeutics and served as expert consultant to the National Institute of Health’s Immune Tolerance Network.

At EpiVax, Rosenberg will support clients developing vaccines and biologics for regulatory review, the company says. She will also work with EpiVax scientists on several internal research programs.